glp 1 ra therapy History of glucagon-like peptide-1 receptor agonists Mechanisms of GLP-1 Receptor Agonists

(PubMed) Parisi V, Centofanti M, Ziccardi L, et al

(2022) 221:e202107114

GIP receptor activation enhances insulin secretion in a glucose-dependent manner, meaning it boosts insulin when blood sugar is high but has minimal effect when blood sugar is normal

Via screening 18 HDACs for the potential delactylase activity, Zhao and colleagues reported that HDAC1-3 and SIRT1-3 could cleave L-lactyllysine marks in vitro [95], especially for nuclear HDAC1-3 serving as the most robust delactylases, suggesting a critical role of HDAC1-3 for the removal of histone lactylation [95]

This initial blood work serves two main purposes: it confirms that the medication is appropriate for you and establishes a starting point to measure your progress against